
Biotechnology
Biotechnology company VistaGen Therapeutics Inc. (NASDAQ:VTGN) was an investor’s dream in 2017. This penny stock did what so few can; it soared from $0.92 to $2.55 in a 24-hour period. However, less than two weeks ... [Read]